Farnes I, Lund-Iversen M, Aabakken L, Verbeke C, et al. Molecular testing for personalized therapy is underutilized in patients with borderline resectable and locally advanced pancreatic cancer - real world data from the NORPACT-2 study. Scand J Gastroenterol 2024 Jul 3:1-4. doi: 10.1080/00365521.2024.2373115.
PMID: 38957079